Decision: Favourable

Decisions Table

Study Title:

Feasibility study of the HighLife 28mm trans-septal transcatheter mitral valve in patients with moderate-severe or severe mitral regurgitation and at high surgical risk

  • NREC Code:

    22-NREC-MD-011

  • Decision:

    Favourable

  • Meeting Date:

    19/05/2022

  • Study Type:

    MD application

  • Principal Investigator:

    Prof Mark Spence

  • PI Institution:

    Mater Private Hospital Dublin

  • Sponsor:

    HighLife SAS

Scroll to Top